THE imi project DRIVE EXPLAINS ITS UNIQUE AND INNOVATIVE GOVERNANCE IN A NEW VIDEOUnderstanding the effectiveness of influenza vaccinesis a priority for both public health experts and vaccine manufacturers. DRIVE is a public-private partnership initiative setup to (...) -
Read more
Project Update
THE NEURONET COORDINATION AND SUPPORT ACTION ON NEURODEGENERATION RESEARCH, led by SYNAPSE, LAUNCHES ITS WEBSITEThe Neuronet (Efficiently Networking European Neurodegeneration Research) communication team is proud to announce the launch of the official project website (...) -
Read more
Project Update
NEURONET 1st SCIENTIFIC COORDINATION BOARD MEETING BRINGS TOGETHER THE LEADERS FROM IMI NEURODEGENERATIVE DISEASE PROJECTSNEURONET, the new Innovative Medicines Initiative (IMI) Coordination and Support Action (CSA) aiming to support and better integrate projects in the IMI Neurodegenerative (...) -
Read more
Project Update
INNOVATIVE MEDICINES INITIATIVE LAUNCHES TRANSLATIONAL SAFETY BIOMARKER PIPELINE PROJECT The Synapse team is delighted to announce the launch of a new Innovative Medicines Initiative project, the Translational Safety Biomarker Pipeline (TransBioLine) Project (...) -
Read more
Project Update
HTX PROJECT STARTS ITS FIVE‐YEAR PROGRAMMEThe SYNAPSE team is delighted to announce the launch of a new Horizon 2020 project, the HTx Project, which will operate in Europe for the coming five years, 2019 – 2023.The overall objective of HTx is to create a framework for next generation Health Technology Assessment (...) -
Read more
Project Update